Beth Israel Deaconess Medical Center, a Framingham biotechnology company, and an international research group are joining in a research initiative aimed at improving the diagnosis and treatment for one of the deadliest forms of cancer. James Moser, associate professor of surgery at Beth Israel Deaconess Medical Center, is quoted.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?